FDA document outlines new mammo appeals process

By AuntMinnie.com staff writers

July 20, 2020 -- The U.S. Food and Drug Administration (FDA) has released a draft guidance document with new options for mammography facilities that want to appeal accreditation decisions.

The guidance informs mammography facilities how they can request an additional review of an appeals decision not in their favor regarding accreditation, suspension, or revocation of a Mammography Quality Standards Act (MQSA) certificate or patient and physician notification orders.

Under the new guidance, facilities that want to challenge the suspension or revocation of an MQSA certificate can either request an informal regulatory hearing before the FDA or, if applicable, present a challenge to State Certification Agencies. Facilities that wish to appeal patient and physician notification orders should request supervisory review of the order and submit the appeal to the next level supervisor.

The FDA is accepting comments on the draft guidance through September 21. When implemented, the new guidance will replace the existing appeals processes outlined in section 4.5 of the 2019 Center for Devices and Radiological Health Appeals Processes guidance document.

Copyright © 2020 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking